FLUOROCHEM
Gujarat Fluorochemicals Limited
Specialty chemicals company making fluoropolymers and refrigerant gases
Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals
gfl.co.in(opens the company website in a new tab)Key metrics
Price as of 2026-10-16
Stock price
₹4402.90
Market cap
48,242 Cr
Stock P/E
78.4
P/B
6.16
Dividend yield
0.1%
ROE (FY26)
7.3%
ROCE (FY26)
9.3%
Operating margin (FY26)
18.5%
Debt / equity (FY26)
0.28
OCF / EBITDA (FY26)
74.4%
OCF / EBITDA (3Y)
62.7%
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What you need to know
Gujarat Fluorochemicals (GFL) makes fluoropolymers and refrigerant gases that it sells to customers in India and abroad, and is building a battery materials business (LiPF6 salt, cathode active material and related products).
Company snapshot
2ndBy market cap
Ranked among 68 companies in Specialty Chemicals.
What we see
Positives
- ✓Debt-to-equity of 0.28x — the company is largely funded by its own money, not borrowed funds.
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 947 Cr | 992 Cr | 1,133 Cr | 1,176 Cr | 1,188 Cr | 1,148 Cr | 1,225 Cr | 1,281 Cr | 1,210 Cr | 1,136 Cr | 1,369 Cr | 1,588 Cr |
| Operating expenses (approx.) | 784 Cr | 786 Cr | 895 Cr | 914 Cr | 893 Cr | 854 Cr | 919 Cr | 937 Cr | 846 Cr | 861 Cr | 1,061 Cr | 1,160 Cr |
| EBITDA | 163 Cr | 206 Cr | 238 Cr | 262 Cr | 295 Cr | 294 Cr | 306 Cr | 344 Cr | 364 Cr | 275 Cr | 308 Cr | 428 Cr |
| OPM % | 17.2% | 20.8% | 21.0% | 22.3% | 24.8% | 25.6% | 25.0% | 26.9% | 30.1% | 24.2% | 22.5% | 27.0% |
| Other income | 14 Cr | 13 Cr | 18 Cr | 9 Cr | 9 Cr | 14 Cr | 26 Cr | 23 Cr | 6 Cr | 7 Cr | 6 Cr | 12 Cr |
| Interest | 34 Cr | 37 Cr | 34 Cr | 37 Cr | 42 Cr | 42 Cr | 26 Cr | 30 Cr | 33 Cr | 33 Cr | 42 Cr | 26 Cr |
| Depreciation | 68 Cr | 72 Cr | 81 Cr | 85 Cr | 90 Cr | 91 Cr | 89 Cr | 90 Cr | 91 Cr | 89 Cr | 97 Cr | 102 Cr |
| Profit before tax | 75 Cr | 110 Cr | 141 Cr | 149 Cr | 172 Cr | 175 Cr | 217 Cr | 247 Cr | 246 Cr | 143 Cr | 171 Cr | 310 Cr |
| Tax % | 29.5% | 27.4% | 28.4% | 27.5% | 29.7% | 28.0% | 12.0% | 25.5% | 27.2% | 28.7% | 36.3% | 29.4% |
| Net profit | 53 Cr | 80 Cr | 101 Cr | 108 Cr | 121 Cr | 126 Cr | 191 Cr | 184 Cr | 179 Cr | 102 Cr | 109 Cr | 219 Cr |
| EPS (₹) | ₹4.80 | ₹7.29 | ₹9.19 | ₹9.81 | ₹10.99 | ₹11.47 | ₹17.39 | ₹16.75 | ₹16.31 | ₹9.29 | ₹9.92 | ₹20.17 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 20191 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,729 Cr | 2,606 Cr | 2,651 Cr | 3,954 Cr | 5,685 Cr | 4,281 Cr | 4,737 Cr | 4,996 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 1,941 Cr | 2,135 Cr | 1,978 Cr | 2,756 Cr | 3,638 Cr | 3,326 Cr | 3,580 Cr | 3,705 Cr | Sign in free for the trailing twelve months |
| EBITDA | 788 Cr | 472 Cr | 673 Cr | 1,198 Cr | 2,047 Cr | 955 Cr | 1,157 Cr | 1,291 Cr | Sign in free for the trailing twelve months |
| OPM % | 28.9% | 18.1% | 25.4% | 30.3% | 36.0% | 22.3% | 24.4% | 25.8% | Sign in free for the trailing twelve months |
| Other income | 86 Cr | 184 Cr | 124 Cr | 131 Cr | 90 Cr | 60 Cr | 58 Cr | 42 Cr | Sign in free for the trailing twelve months |
| Interest | 56 Cr | 105 Cr | 113 Cr | 78 Cr | 117 Cr | 133 Cr | 147 Cr | 138 Cr | Sign in free for the trailing twelve months |
| Depreciation | 164 Cr | 192 Cr | 202 Cr | 205 Cr | 236 Cr | 286 Cr | 355 Cr | 367 Cr | Sign in free for the trailing twelve months |
| Profit before tax | 645 Cr | 332 Cr | 482 Cr | 1,045 Cr | 1,785 Cr | 595 Cr | 713 Cr | 807 Cr | Sign in free for the trailing twelve months |
| Tax % | -93.1% | 43.0% | 145.9% | 25.8% | 25.9% | 26.9% | 23.4% | 28.9% | Sign in free for the trailing twelve months |
| Net profit | 1,246 Cr | 189 Cr | -222 Cr | 776 Cr | 1,323 Cr | 435 Cr | 546 Cr | 574 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | — | ₹17.23 | ₹-20.17 | ₹70.63 | ₹120.44 | ₹39.60 | ₹49.69 | ₹52.26 | Sign in free for the trailing twelve months |
| Dividend payout % | — | — | — | 2.8% | 3.3% | 5.1% | 6.0% | 5.7% | Sign in free for the trailing twelve months |
Sign in free for the trailing twelve months
The latest four quarters added up, next to each full year
- 1Mar 2019: FY19 is the demerged chemicals business (the "Chemical Business Undertaking", before this company held it), as printed in the company's FY20 annual report.
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 20191 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | — | 11 Cr | 11 Cr | 11 Cr | 11 Cr | 11 Cr | 11 Cr | 11 Cr |
| Reserves | — | 3,705 Cr | 3,482 Cr | 4,244 Cr | 5,510 Cr | 5,925 Cr | 7,242 Cr | 7,855 Cr |
| Borrowings | — | 1,520 Cr | 1,410 Cr | 1,553 Cr | 1,478 Cr | 1,996 Cr | 1,988 Cr | 2,199 Cr |
| Other liabilities | — | 842 Cr | 1,079 Cr | 1,095 Cr | 1,372 Cr | 1,302 Cr | 1,322 Cr | 1,771 Cr |
| Total liabilities | — | 6,067 Cr | 5,969 Cr | 6,878 Cr | 8,371 Cr | 9,234 Cr | 10,609 Cr | 11,883 Cr |
| Fixed assets (net) | — | 2,327 Cr | 2,289 Cr | 2,447 Cr | 2,963 Cr | 4,055 Cr | 4,040 Cr | 4,509 Cr |
| CWIP | — | 318 Cr | 400 Cr | 680 Cr | 1,142 Cr | 1,091 Cr | 1,524 Cr | 1,890 Cr |
| Investments | — | 269 Cr | 98 Cr | 26 Cr | 4 Cr | 4 Cr | 293 Cr | 278 Cr |
| Loans & advances | — | 42 Cr | 50 Cr | 37 Cr | 28 Cr | 27 Cr | 25 Cr | 16 Cr |
| Inventories | — | 813 Cr | 864 Cr | 947 Cr | 1,485 Cr | 1,571 Cr | 1,820 Cr | 1,933 Cr |
| Trade receivables | — | 565 Cr | 667 Cr | 778 Cr | 1,107 Cr | 845 Cr | 1,197 Cr | 1,282 Cr |
| Cash & bank | — | 17 Cr | 12 Cr | 26 Cr | 24 Cr | 31 Cr | 55 Cr | 215 Cr |
| Other assets | — | 1,717 Cr | 1,590 Cr | 1,937 Cr | 1,618 Cr | 1,609 Cr | 1,655 Cr | 1,760 Cr |
| Total assets | — | 6,067 Cr | 5,969 Cr | 6,878 Cr | 8,371 Cr | 9,234 Cr | 10,609 Cr | 11,883 Cr |
- 1Mar 2019: FY19 is the demerged chemicals business (the "Chemical Business Undertaking", before this company held it), as printed in the company's FY20 annual report.
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 20191 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 782 Cr | 546 Cr | 616 Cr | 741 Cr | 739 Cr | 626 Cr | 545 Cr | 961 Cr |
| Cash from investing | -428 Cr | -1,192 Cr | -373 Cr | -584 Cr | -476 Cr | -966 Cr | -1,120 Cr | -1,168 Cr |
| Cash from financing | 110 Cr | 622 Cr | -248 Cr | -144 Cr | -264 Cr | 348 Cr | 599 Cr | 367 Cr |
| Net cash flow | 464 Cr | -24 Cr | -5 Cr | 14 Cr | -2 Cr | 7 Cr | 24 Cr | 160 Cr |
| Free cash flow (OCF − Capex) | 261 Cr | -650 Cr | 343 Cr | 67 Cr | 8 Cr | -344 Cr | -336 Cr | -291 Cr |
- 1Mar 2019: FY19 is the demerged chemicals business (the "Chemical Business Undertaking", before this company held it), as printed in the company's FY20 annual report.
Ratios
| Metric | Mar 20191 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| ROCE % | — | 8.4% | 12.2% | 19.4% | 27.2% | 9.2% | 9.3% | 9.3% |
| ROE % | — | 5.3% | -6.3% | 18.3% | 24.1% | 7.3% | 7.5% | 7.3% |
| Debtor days | — | 79 | 92 | 72 | 71 | 72 | 92 | 93 |
| Inventory days | — | 311 | 350 | 288 | 292 | 371 | 397 | 430 |
| Days payable | — | 140 | 137 | 156 | 136 | 122 | 132 | 123 |
| Cash conversion cycle | — | 250 | 305 | 204 | 227 | 320 | 357 | 401 |
| OCF / EBITDA % | 99.2% | 115.9% | 91.6% | 61.9% | 36.1% | 65.6% | 47.1% | 74.4% |
| OCF / EBITDA % (3 years) | — | — | 100.6% | 81.3% | 53.5% | 50.2% | 45.9% | 62.7% |
| Debt / equity | — | 0.41 | 0.41 | 0.37 | 0.27 | 0.34 | 0.27 | 0.28 |
| Current ratio | — | 1.05 | 1.06 | 1.28 | 1.48 | 1.36 | 1.70 | 1.72 |
| Net debt / EBITDA | 0.00 | 3.19 | 2.08 | 1.28 | 0.71 | 2.06 | 1.67 | 1.54 |
- 1Mar 2019: FY19 is the demerged chemicals business (the "Chemical Business Undertaking", before this company held it), as printed in the company's FY20 annual report.